Document is current
Any future updates will be listed below
-
Authors
Hsu, Kuo-Sheng
Dunleavey, James M.
Szot, Christopher
Yang, Liping
Hilton, Mary Beth
Morris, Karen
Seaman, Steven https://orcid.org/0000-0003-3349-3334
Feng, Yang
Lutz, Emily M.
Koogle, Robert
Tomassoni-Ardori, Francesco
Saha, Saurabh
Zhang, Xiaoyan M.
Zudaire, Enrique
Bajgain, Pradip https://orcid.org/0000-0002-4719-8451
Rose, Joshua https://orcid.org/0000-0003-2490-7080
Zhu, Zhongyu
Dimitrov, Dimiter S. https://orcid.org/0000-0002-2258-1024
Cuttitta, Frank
Emenaker, Nancy J.
Tessarollo, Lino https://orcid.org/0000-0001-6420-772X
St. Croix, Brad https://orcid.org/0000-0002-6246-0374
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Division of Cancer Prevention, National Cancer Institute
BioMed Valley Discoveries
- License Information
-
More Information
Article History
Received: 18 March 2022
Accepted: 1 November 2022
First Online: 18 November 2022
Competing interests
: S. Saha, X.M.Z., E.Z., Z.Z., D.S.D., and B.S.C. are inventors of intellectual property related to TEM8 antibodies, and B.S.C. and D.S.D. have received research support through a CRADA with BVD. The remaining authors declare no competing interests.
